Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gynoclear is a modified traditional Chinese herbal medicine (TCM) formulation developed by Metagenics (Aust) Pty Ltd for the management of endometriosis-related pain. Based on the classical Gui Zhi Fu Ling Wan (GZFLW) formula, Gynoclear is a multi-herb botanical product delivered in capsule form. It contains six active herbal ingredients: *Carthamus tinctorius* (Safflower), *Cinnamomum cassia* (Chinese cinnamon), *Poria cocos* (Hoelen), *Paeonia suffriticosa* (Tree peony), *Paeonia lactiflora* (Peony), and *Salvia miltiorrhiza* (Red sage). The formulation differs from the traditional GZFLW by the addition of *Salvia miltiorrhiza* (Dan Shen) and the substitution of *Semen persicae* (Tao Ren) with *Carthamus tinctorius* (Hong Hua). Gynoclear is currently being evaluated in clinical trials for its efficacy in reducing non-cyclical pelvic pain, dysmenorrhoea, and dyspareunia in women with endometriosis. Its therapeutic effects are attributed to broad anti-inflammatory activity and potential modulation of estrogen receptor pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gynoclear.